Journal Mobile Options
Table of Contents
Vol. 77, No. 3, 2006
Issue release date: July 2006
Pharmacology 2006;77:130–136

Anti-Inflammatory Activity of Thymol: Inhibitory Effect on the Release of Human Neutrophil Elastase

Braga P.C. · Dal Sasso M. · Culici M. · Bianchi T. · Bordoni L. · Marabini L.
aDepartment of Pharmacology, School of Medicine, University of Milan, and bAVIS, Milan, Italy

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Elastase, a serine proteinase released by activated human neutrophils, can degrade a wide variety of biomacromolecules including elastin, and is considered a marker of inflammatory diseases. As the logical strategy to protect tissue is to inhibit excessive elastase activity, experimental and clinical researches have concentrated on trying to find efficient elastase inhibitors. As thymol, one of the major components of thyme oil with a phenolic structure, has been credited with a series of pharmacological properties, that include antimicrobial and antioxidant effects, the aim of this study was to explore whether it can also interfere with the release of elastase by human neutrophils stimulated with the synthetic chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine (fMLP). After the neutrophils were incubated with increasing amounts of thymol (2.5, 5, 10, 20 µg/ml), elastase release was initiated by fMLP and measured using MeO-Suc-Ala-Ala-Pro-Val-MCA. The results showed that thymol inhibited fMLP-induced elastase release in a concentration-dependent manner, with the effects of 10 and 20 µg/ml being statistically significant. The behavior of cytosolic calcium mobilization revealed by fura-2 closely resembled that of elastase, thus suggesting that they may be related. The hydrophobic nature of thymol means that it can approach ion channel proteins through the lipid phase of the membrane, alter the local environment of calcium channels and thus inhibit capacitative calcium entry. In brief, thymol inactivates calcium channels machinery, thus triggering a corresponding reduction in elastase. The antibacterial and antimycotic activity of thymol is already well known, but our findings that it inhibits elastase extend our knowledge of the anti-inflammatory activity of this interesting molecule that is already credited with antioxidant activity. These two latter characteristics make thymol a molecule that can have helpful effects in controlling the inflammatory processes present in many infections.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Smith JA: Neutrophils, host defense, and inflammation: a double-edged sword. J Leukoc Biol 1994;56:672–686.
  2. Witko-Sarsat V, Rien P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli L: Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest 2000;80:617–653.
  3. Babior BM: Oxidants from phagocytes: agents of defense and destruction. Blood 1984;64:959–966.
  4. Travis J: Structure, function, and control of neutrophil proteinases. Am J Med 1988;84:37–42.
  5. Johansson S, Goransson U, Luijendijk T, Backlund A, Claeson P, Bohlin L: A neutrophil multitarget functional bioassay to detect anti-inflammatory natural products. J Nat Prod 2002;65:32–41.
  6. Bekaroglu M, Deger O, Karahan SC, Bilici M, Solylu C, Orem A: Effects of antidepressant treatments on polymorphonuclear elastase levels in patients with depression. J Affect Disord 2000;59:175–182.
  7. Werner U, Seitz O, Szelenyi L: Stimulated elastase release from human leukocytes: influence of anti-asthmatic, anti-inflammatory and calcium antagonist drugs in vitro. Agents Actions 1993;38:C112–C114.

    External Resources

  8. Fujie K, Shinguh Y, Inamura N, Yasumitsu R, Okamoto M, Okuhara M: Release of neutrophil elastase and its role in tissue injury in acute inflammation: effect of the elastase inhibitor, Fr 134043. Eur J Pharmacol 1999;374:117–125.
  9. Tyagi SC: Reversible inhibition of neutrophil elastase by thiol-modified α1-protease inhibitor. J Biol Chem 1991;15:5279–5285.
  10. Mellet P, Boudier C, Mely Y, Bieth JG: Stopped flow fluorescence energy transfer measurement of the rate constants describing the reversible formation and the irreversible rearrangement of the elastase-α1-proteinase inhibitor complex. J Biol Chem 1998;273:9119–9123.
  11. Bernstein PR, Edwards PD, Williams JC: Inhibitors of human leukocyte elastase. Prog Med Chem 1994;31:59–120.
  12. Siedle B, Gustavsson L, Johansson S, Murillo R, Castro V, Bohlin L, Merfort I: The effect of sesquiterpene lactones on the release of human neutrophil elastase. Biochem Pharmacol 2003;65:897–903.
  13. Daels-Rakotoarison DA, Kouakou G, Gressier B, Dine T, Brunet C, Luyckx M, Bailleul F, Trotin F: Effects of a caffeine-free cola nitida nuts extract on elastase/α1-proteinase inhibitor balance. J Ethnopharmacol 2003;89:143–150.
  14. Dorman HJ, Deans SG: Antimicrobial agents from plants antibacterial activity of plant volatile oils. J Appl Microbiol 2000;88:308–316.
  15. Cosentino S, Tuberoso CIG, Pisano B, Satta M, Arzedi E, Plamas F: In vitro antimicrobial activity and chemical composition of Sardinians Thymus essential oils. Lett Appl Microbiol 1999;29:130–135.
  16. Crespo ME, Jimenez J, Gomis E, Navarro C: Antibacterial activities of the essential oil of Thymus serpylloides subspecies gadorensis. Microbios 1990;61:181–184.
  17. Miura K, Kikuzaki H, Nakatani N: Antioxidant activity of chemical components from sage (Salvia officinalis L.) and thyme (Thymus vulgaris L.) measured by the oil stability index method. J Agric Food Chem 2002;50:1845–1851.
  18. Schwarz K, Ernst H, Ternes W: Evaluation of antioxidative constituents from thyme. J Sci Food Agric 1996;70:217–223.
  19. Dal Sasso M, Culici M, Guffanti EE, Mucci M, Braga PC: Thymol inhibitory activity on Escherichia coli and Staphylococcus aureus adhesion to human vaginal cells. J Essent Oil Res 2006 (accepted).
  20. Culici M, Capretti V, Dal Sasso M, Guffanti EE, Nucci M, Braga PC: Evaluation of thymol inhibition of Candida albicans adhesiveness to human vaginal cells. GIMMOC 2005;9:107–114.
  21. Braga PC, Dal Sasso M, Culici M, Galastri L, Marceca MT, Guffanti EE: Antioxidant potential of thymol determined by chemiluminescence inhibition in human neutrophils and cell-free systems. Pharmacology 2006;76:61–68.
  22. Sklar LA, McNeil VM, Jesaitis AJ, Painter RG, Cochrane G: A continuous, spectroscopic analysis of the kinetics of elastase secretion by neutrophils. The dependence of secretion upon receptor occupancy. J Biol Chem 1982;257:5471–5475.
  23. De Vries GW, Amdahl LD, Kramer KD, Wheeler LA: Inhibition by manoalide of fMLP-stimulated elastase release from human neutrophils. Biochem Pharmacol 1990;40:2487–2494.
  24. Southwick FS, Stossel TP: Contractile proteins in leukocyte function. Semin Hematol 1983;20:305–321.
  25. Steel HC, Anderson R: Itraconazole antagonize store-operated influx of calcium into chemoattractant-activated human neutrophils. Clin Exp Immunol 2004;136:255–261.
  26. Grynkiewicz G, Poenie M, Tsien RY: New generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440–3450.
  27. Hansen CA, Monk JR, Williamson JR: Measurement of intracellular free calcium to investigate receptor-mediated calcium signalling. Meth Enzymol 1990;191:691–706.
  28. Vasange M, Liu B, Welch CJ, Rolfsen W, Bohlin L: The flavonoid constituents of two polypodium species (Calaguala) and their effect on the elastase release in human neutrophils. Planta Med 1997;63:511–517.
  29. Baylac S, Racine S: Inhibition of human leukocyte elastase by natural fragrant extracts of aromatic plants. Int J Aromather 2004;14:179–182.
  30. Rotondo S, Rajtar G, Manarini S, Celardo A, Rotilio D, de Gaetano G, Evangelista V, Cerletti C: Effects of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. Br J Pharmacol 1998;123:1691–1699.
  31. Melzig MF, Loser B, Ciesielski S: Inhibition of neutrophil elastase activity by phenolic compounds from plants. Pharmazie 2001;56:967–970.
  32. Lee KK, Cho JJ, Park EJ, Choi JD: Anti-elastase and anti-hyaluronidase of phenolic substance from Areca catechu as a new anti-ageing agent. Int J Cosmet Sci 2001;23:341–346.
  33. Dewhirst FE: Structure-activity relationship for inhibition of prostaglandin cyclooxygenase by phenolic compounds. Prostaglandins 1980;20:209–222.
  34. Lindgren JA, Claesson HE, Hammarström S: Inhibition of prostaglandin synthesis in mouse 3T3 fibroblasts and human platelets by substituted phenols. Prostaglandins 1977;13:1093–1100.
  35. Youdim KA, Deans SG: Effect of thyme oil and thymol dietary supplementation on the antioxidant status and fatty acid composition of the ageing rat brain. Br J Nutr 2000;83:87–93.
  36. Youdim KA, Deans SG: Dietary supplementation of thyme (Thymus vulgaris L.) essential oil during the lifetime of the rat: its effects on the antioxidant status in liver, kidney and heart tissues. Mech Age Dev 1999;109:163–175.
  37. Youdim KA, Deans SG: Beneficial effects of thyme oil on age-related changes in the phospholipid C20 and C22 polyunsaturated fatty acid composition of various rat tissues. Biochim Biophys Acta 1999;1438:140–146.
  38. Nick JA, Avdi NJ, Young SK, Knall C, Gerwins P, Johnson GL, Worthen GS: Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and fMLP. J Clin Invest 1997;99:975–986.
  39. Suda T, Suzuki Y, Matsui T, Inoue T, Niide O, Yoshimaru T, Suziki H, Ra C, Ochiai T: Dapsone suppresses human neutrophil superoxide production and elastase release in a calcium-dependent manner. Br J Dermatol 2005;152:887–895.
  40. Lew DP, Andersoon T, Hed J, Di Virgilio F, Pozzan T, Stendhal O: Ca2+ dependent and Ca2+ independent phagocytosis in human neutrophils. Nature 1985;315:509–511.
  41. Lew DP, Wollheim CB, Waldvogel FA, Pozzan T: Modulation of cytosolic free calcium transients by changes in intracellular calcium-buffering capacity: correlation with exocytosis and O2 production in human neutrophils. J Cell Biol 1984;99:1212–1220.
  42. Gandry M, Combadiere C, Marquetty C, Hakin JA: Comparison of priming effect of phorbal myristate acetate and phorbol dibutyrate on fMLP induced oxidative burst in human neutrophils. Immunopharmacology 1990;20:45–56.
  43. Burgess GM, McKinney JS, Irvine RF, Berridge MJ, Hoyle PC, Purtney JW Jr: Inositol 1,4,5-triphosphate may be a signal for f-Met-Leu-Phe-induced intracellular Ca mobilisation in human leukocytes (HL-60 cells). FEBS Lett 1984;176:193–196.
  44. Baggiolini M, Boulay F, Badwey JA, Curnutte JT: Activation of neutrophil leukocytes: chemoattractant receptors and respiratory burst. FASEB J 1993;7:1004–1010.
  45. Berridge MJ, Irvine RF: Inositol triphosphate, a novel second messenger in cellular signal transduction. Nature 1984;312:315–321.
  46. Chen LW, Lin MW, Hsu CM: Different pathways leading to activation of extracellular signal-regulated kinase and p38 MAP kinase by formyl-methionyl-leucyl-phenylalanine or platelet-activating factor in human neutrophils. J Biomed Sci 2005;12:311–319.
  47. Truett AP, Verghese MD, Dillon SB, Snyderman R: Calcium influx stimulates a second pathway for sustained diacylglycerol production in leukocytes activated by chemoattractants. Proc Nat Acad Sci USA 1988;85:1549–1553.
  48. Khalfi F, Gressier B, Brunet C, Dine T, Luyckx M, Cazin M, Cazin JC: Involvement of the extracellular calcium in the release of elastase and the human neutrophils oxidative burst. Cell Mol Biol 1996;42:1211–1218.
  49. Jan CR, Ho CM, Wu SN, Tseng CJ: Multiple effects of econazole on calcium signalling: depletion of thapsigargin-sensitive calcium store, activation of extracellular calcium influx, and inhibition of capacitative calcium entry. Biochim Biophys Acta 1999;1448:533–542.
  50. Chen LW, Jan CR: Mechanisms and modulation of formyl-methionyl-leucyl-phenylalanine fMLP-induced Ca2+ mobilization in human neutrophils. Int Immunopharmacol 2001;1:1341–1349.
  51. Haeseler G, Moue D, Grosskreutz J, Bufler J, Neutwig B, Piepenbrock S, Dengler R, Leuwer M: Voltage-dependent block of neuronal and skeletal muscle sodium channels by thymol and menthol. Eur J Anaesthesiol 2002;19:571–579.
  52. Szentandrassy N, Szentesi P, Magyar J, Nanasi PP, Csernoch L: Effect of thymol on kinetic properties of Ca and K currents in rat skeletal muscle. BMC Pharmacol 2003;3:1–8.
  53. Magyar J, Szentandrassy N, Banyasz T, Fulop L, Varro A, Nanasi PP: Effects of thymol on calcium and potassium currents in canine and human ventricular cardiomyocytes. Br J Pharmacol 2002;136:330–338.
  54. Huang MH, Liao LF, Kuo SH, Chen CL, Shen AY: Effects of 4-piperidinomethyl-2-isopropyl-5-methylphenol on oxidative stress and calcium current. J Pharm Pharmacol 2005;57:1191–1197.
  55. Shen AY, Huang MH, Liao LF, Wang TS: Thymol analogues with antioxidant and L-type calcium current inhibitory activity. Drug Dev Res 2005;64:195–202.
  56. Magyar J, Szentandrassy N, Banyasz T, Fulop L, Varro A, Nanasi PP: Effects of terpenoid phenol derivatives on calcium current in canine and human ventricular cardiomyocytes. Eur J Pharmacol 2004;487:29–36.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50